True Wealth Design
FENC icon

True Wealth Design’s Fennec Pharmaceuticals FENC Stock Holding History

True Wealth Design’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$96 Hold
9
– – ﹤0.01% 2447
2026
Q2 		$97 Sell
9
-9
-50% -$73 ﹤0.01% 2542
2026
Q1 		$111 Buy
18
+17
+1,700% +$131 ﹤0.01% 2451
2025
Q4 		$8 Buy
+1
New +$8 ﹤0.01% 2533

Other funds holding FENC

Essex Investment Management
Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
PWMG
Private Wealth Management Group Princeton, New Jersey $445M AUM 13.54% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

True Wealth Design's FENC Position: Q3 2026 in Review

True Wealth Design held its Fennec Pharmaceuticals (FENC) position steady in Q3 2026 at 9 shares worth $96. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

True Wealth Design first reported a position in FENC in Q4 2025 and has held it in 4 quarters since. The position peaked at $111 in Q1 2026. 12 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

  • True Wealth Design held 9 shares of Fennec Pharmaceuticals worth $96 as of Q3 2026.
  • True Wealth Design left its Fennec Pharmaceuticals share count unchanged in Q3 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2447 holding.
  • True Wealth Design first reported a position in Fennec Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • True Wealth Design's Fennec Pharmaceuticals position peaked at $111 in Q1 2026.
  • 12 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.